[ad_1]
(MedPage Today) — SAN DIEGO — Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed.
Twice-yearly injections cut total nasal polyps score by a mean of 0.7 more than…
[ad_2]
Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/114450
Author :
Publish date : 2025-03-02 22:31:57
Copyright for syndicated content belongs to the linked Source.
Twice-Yearly Biologic Effective Against Nasal Polyps